Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells

British Journal of Clinical Pharmacology

Volumn 41, Issue 3, 1996, Pages 201-206

  Eaton, E Alison ^a   Walle, U Kristina ^a   Wilson, Hugh M ^a   Aberg, Gunnar ^b   Walle, Thomas ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b SUNOVION PHARMACEUTICALS INC   (United States)

Author keywords

Albuterol; BEAS 2B cells; Enantioselectivity; Lung bronchial epithelial cells; Phenolsulphotransferase; Salbutamol; Stereoselectivity; Sulphation

Indexed keywords

SALBUTAMOL; SULFOTRANSFERASE;

ARTICLE; BRONCHUS MUCOSA; CYTOSOL; DRUG CLEARANCE; DRUG CONJUGATION; DRUG METABOLISM; DRUG PROTEIN BINDING; ENANTIOMER; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG; PRIORITY JOURNAL; STEREOSPECIFICITY;

EID: 0029874113     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1996.tb00183.x     Document Type: Article

References (27)

1. Morgan DJ. Clinical pharmacokinetics of β-agonists. Clin Pharmacokinet 1990; 18: 270-294.
2. Chapman ID, Buchheit KH, Manley P, Morley J. Active enantiomers may cause adverse effects in asthma. Trends Pharmacol Sci 1992; 13: 231-232.
3. Sanjar S, Kristersson A, Mazzoni L, Morley J, Schaeublin E. Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline. J Physiol 1990; 425: 43-54.
4. Lin C, Li Y, McGlotten J, Morton JB, Symchowics S. Isolation and identification of the major metabolite of albuterol in human urine. Drug Metab Dispos 1977; 5: 234-238.
5. Morgan DJ, Paull JD, Richmond BH, Wilson-Evered E, Ziccone SP: Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol 22: 587-593.
6. Walle UK, Pesola GR, Walle T. Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. Br J Clin Pharmacol 1993; 35: 413-418.
7. Walle T, Walle UK, Thornburg KR, Schey KL. Stereoselective sulfation of albuterol in humans: biosynthesis of the sulfate conjugate by Hep G2 cells. Drug Metab Dispos 1993; 21: 76-80.
8. Walle T, Walle UK, Shwed JA, Thornburg KR, Mathis CE, Pesola GR. Human phenolsulfotransferases: chiral substrates and expression in Hep G2 cells. Chem Biol Interact 1994; 92: 47-55.
9. Sundaram RS, Szumlanski C, Otterness D, Van Loon JA, Weinshilboum RM. Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification. Drug Metab Dispos 1989; 17: 255-264.
10. Sekura RD, Jakoby WB. Phenol sulfotransferases. J Biol Chem 1979; 254: 5658-5663.
11. Ke Y, Reddel RR, Gerwin BI, et al. Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation 1988; 38: 60-66.
12. Anderson RJ, Weinshilboum RM. Phenolsulfotransferase in human tissue: Radiochemical enzymatic assay and biochemical properties. Clin Chim Acta 1980; 103: 79-90.
13. Foldes A, Meek JL. Rat brain phenolsulfotransferase - partial purification and some properties. Biochim Biophys Acta 1973; 327: 365-374.
14. Weinshilboum RM. Phenol sulfotransferase in humans: properties, regulation, and function. FASEB J 1986; 45: 2223-2228.
15. Shwed JA, Walle UK, Walle T. Hep G2 cell line as a human model for sulphate conjugation of drugs. Xenobiotica 1992; 22: 973-982.
16. Baranczyk-Kuzma A, Szymczyk T. Lung phenol sulfotransferases - Thermal stability of human and bovine enzymes. Biochem Pharmacol 1986; 35: 995-999.
17. Segel IH. Enzyme kinetics, pp. 113-115, John Wiley & Sons, New York, 1975.
18. 2-agonist drug albuterol by the human liver. Res Commun Chem Pathol Pharmacol 1992; 75: 125-128.
19. Boulton DW, Fawcett JP. Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br J Clin Pharmacol 1996; 41: 35-40.
20. Shenfield GM, Evans ME, Paterson JW. Absorption of drugs by the lungs. Br J Clin Pharmacol 1976; 3; 583-589.
21. Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992; 34: 311-315.
22. Guengerich FP. Purification and characterization of lung enzymes involved in xenobiotic metabolism. In Metabolic activation and toxicity of chemical agents to lung tissue and cells, Vol. 138, ed. Gram TE, pp. 77-87. Pergamon Press, New York, 1993.
23. Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994; 26: 144-160.
24. Mehta R, Cohen GM. Major differences in the extent of conjugation with glucuronic acid and sulphate in human peripheral lung. Biochem Pharmacol 1979; 28: 2479-2484.
25. Pacifici GM, Franchi M, Bencini C, Repetti F, Di Lascio N, Muraro GB. Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica 1988; 18: 849-856.
26. Jones AL, Hume R, Bamforth KJ, Coughtrie MWH. Estrogen and phenol sulfotransferase activities in human fetal lung. Early Human Development 1992; 28: 65-77.
27. Baron J, Voigt JM. Intrapulmonary localization of xenobiotic-metabolizing enzymes. In Metabolic activation and toxicity of chemical agents to lung tissue and cells. Vol. 138, ed. Gram TE, pp. 56-62. Pergamon Press, New York, 1993.